Placebo-controlled trial of risperidone augmentation for SSRI [selective serotonin reuptake inhibitor]-resistant civilian PTSD [post-traumatic stress disorder]
Phase of Trial: Phase II/III
Latest Information Update: 05 Nov 2014
At a glance
- Drugs Risperidone; Sertraline
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 05 Nov 2014 Last checked against ClinicalTrials.gov record.
- 08 Jan 2007 Status change
- 03 Dec 2005 New trial record.